Buffalo-based POP Biotechnologies develops nanotechnology platforms for vaccines, immunotherapies and light-activated cancer drug delivery. Its patented SNAP technology forms nanoliposome vaccines by binding His-tagged antigens to CoPoP liposomes, and has supported EuCorVac-19, a COVID-19 vaccine that met primary endpoints in a Phase 3 study. The company also produces CoPoP under GMP at a 2.5-million-dose scale and is advancing PhotoDOX, which uses red light to trigger localized doxorubicin release in solid tumors.
Good Manufacturing Practice (GMP)
Compliance program
GLP Toxicology
Compliance program
Financial Conflict of Interest Policy
Compliance program
GMP
Quality certification
GLP
Quality certification